Inhaled corticosteroids can reduce osteoporosis in female patients with COPD

@article{Liu2016InhaledCC,
  title={Inhaled corticosteroids can reduce osteoporosis in female patients with COPD},
  author={Shih-Feng Liu and Ho‐Chang Kuo and Guan-Heng Liu and Shu Ho and Huang-Chih Chang and Hung-Tu Huang and Yu-Mu Chen and Kuo-Tung Huang and Kuan-Yi Chen and Wen-Feng Fang and Meng-Chih Lin},
  journal={International Journal of Chronic Obstructive Pulmonary Disease},
  year={2016},
  volume={11},
  pages={1607 - 1614}
}
Background Whether the use of inhaled corticosteroids (ICSs) in patients with COPD can protect from osteoporosis remains undetermined. The aim of this study is to assess the incidence of osteoporosis in patients with COPD with ICS use and without. Patients and methods This is a retrospective cohort and population-based study in which we extracted newly diagnosed female patients with COPD between 1997 and 2009 from Taiwan’s National Health Insurance (TNHI) database between 1996 and 2011… 

Figures and Tables from this paper

Evaluating the association of osteoporosis with inhaled corticosteroid use in chronic obstructive pulmonary disease in Taiwan
TLDR
This population-based study included 891,395 patients with COPD and found new ICS use in COPD patients is associated with increased osteoporosis risk, regardless of exposure period.
Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study
TLDR
It is concluded that patients with COPD have a greater risk of bone fractures and osteoporosis, and high-dose ICS use increased this risk further.
Using Taiwan NHIRD for studying the effect of inhaled corticosteroids on fracture
TLDR
It was observed that long-term use of inhaled corticosteroids may induce osteoporosis and exhibit higher incidence of hip or vertebrate fractures.
Inhaled corticosteroids and fractures in chronic obstructive pulmonary disease: current understanding and recommendations
TLDR
Inhaled corticosteroid should be generally avoided in patients with previous fractures or significant osteoporosis, and close monitoring is recommended for accelerated bone demineralization.
Is Osteoporosis a Common Comorbidity in Different Chronic Airway Diseases?
TLDR
Results suggest that lower BMD in patients with ACO compared to patients with asthma or COPD alone could be a characteristic of the overlap, consistent with results of two aforementioned studies.
Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD
TLDR
Long-term use of inhaled corticosteroids in COPD is associated with a significantly increased risk of side-effects, especially oral candidiasis, dysphonia, pneumonia, mycobacterial disease, diabetes and fractures, which is crucial for the indication of ICSs.
Increased risk of osteoporosis in patients with nonalcoholic fatty liver disease
TLDR
The finding indicates that NAFLD might increase the risk of developing new-onset osteoporosis, especially in patients with lower income and co-morbid with diabetes mellitus and chronic obstructive pulmonary disease, which may be recommended for earlier detection and intervention.
Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today?
TLDR
An overview of current use of ICS in COPD is provided and their value to the current treatment armamentarium is discussed to demonstrate that ICSs can influence the natural course of COPD in at least a subset of patients.
Design of a Clinical Decision Support System for Fracture Prediction Using Imbalanced Dataset
TLDR
Long-term use of inhaled corticosteroids may induce osteoporosis and exhibit higher incidence of hip or vertebrate fractures, and a clinical support system for fracture prediction is designed.
Effect of inhaled corticosteroids on bone mineral density in patients with asthma.
TLDR
In the entire study population, long-term ICS use was safe and was not associated with an increased risk of osteoporosis.
...
...

References

SHOWING 1-10 OF 52 REFERENCES
Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study.
TLDR
No significant effect on BMD was detected for ICS therapy compared with placebo in the TORCH study, and osteoporosis is highly prevalent in patients with COPD, irrespective of gender.
Bone Metabolism Status and Associated Risk Factors in Elderly Patients with Chronic Obstructive Pulmonary Disease (COPD)
TLDR
Multiple regression analysis in COPD group suggests that age, the frequency of acute exacerbation, and BMD are independent risk factors for P1NP, and these results should help to further understand the cause of osteoporosis and fractures and conduce to prevent fractures in patients with COPD.
Patterns of comorbidities in newly diagnosed COPD and asthma in primary care.
TLDR
COPD and asthma are conditions associated with many comorbidities, albeit asthma to a lesser extent than COPD, which had not been systematically reviewed before.
Impact of COPD Exacerbations on Osteoporosis Assessed by Chest CT Scan
TLDR
This is the first longitudinal study to demonstrate that COPD exacerbations are independently associated with osteoporosis progression, and should be evaluated in COPD patients, especially in those with a history of frequent exacerbations.
Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD.
TLDR
A prospective study demonstrates a different, disease-specific, early inflammatory pattern between patients with CAP with and without associated COPD.
Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study.
TLDR
Comorbidities are common in patients hospitalized for a COPD exacerbation, and they are related to short-term prognosis, even after adjustment for age, FEV1, and functional status measured with the Katz index.
Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens.
TLDR
Despite a far lower cumulative GC dose in comparison with patients treated with systemic corticosteroids continuously, after adjusting for BMI and lung function, osteoporosis of the lumbar spine was most frequent in patients receiving > 1,000 mg of prednisolone cumulatively, administered in multiple courses for the treatment of exacerbations of COPD.
Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease.
TLDR
In patients with asthma or mild COPD, there is no evidence of an effect of inhaled corticosteroid at conventional doses given for two or three years on BMD or vertebral fracture.
COPD and osteoporosis.
TLDR
With an increased awareness by pulmonologists and the increased use of preventive strategies, the impact of osteoporosis on those patients with COPD should decrease.
Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study.
TLDR
This study indicates that discontinuation of FP in patients with chronic obstructive pulmonary disease is associated with a more rapid onset and higher recurrence-risk of exacerbations and a significant deterioration in aspects of Health-Related Quality of Life.
...
...